Equilife Laboratories Private Limited

Clarithromycin EP Impurity G  is chemically 6-O-Methylerythromycin A (E)-9-(O-methyloxime) (as per EP). It is also known as Clarithromycin (9E)-O-Methyloxime ; 6-O-Methylerythromycin A (E)-9-(O-methyloxime) ;. Clarithromycin EP Impurity G  is supplied with detailed characterization data compliant with regulatory guideline. Clarithromycin EP Impurity G  can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Clarithromycin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility.

Clarithromycin EP Impurity F is chemically 6,12-di-O-methylerythromycin A (as per EP). It is also known as 12-O-Methyl Clarithromycin ; 6,12-Di-O-methylerythromycin A ;. Clarithromycin EP Impurity F is supplied with detailed characterization data compliant with regulatory guideline. Clarithromycin EP Impurity F can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Clarithromycin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility.

Clarithromycin EP Impurity D is chemically 3″-N-demethyl-6-O-methylerythromycin A (as per EP). It is also known as N-Desmethyl Clarithromycin ; 3″-N-Demethyl-6-O-methylerythromycin A. Clarithromycin EP Impurity D is supplied with detailed characterization data compliant with regulatory guideline. Clarithromycin EP Impurity D can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Clarithromycin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility

Clarithromycin EP Impurity C is chemically 6-O-Methylerythromycin A (E)-9-oxime (as per EP). It is also known as Clarithromycin 9-Oxime ; 6-O-Methylerythromycin A (E)-9-oxime. Clarithromycin EP Impurity C is supplied with detailed characterization data compliant with regulatory guideline. Clarithromycin EP Impurity C can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Clarithromycin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility.

Clarithromycin EP Impurity B is chemically 6-O-Methyl-15-norerythromycin A (as per EP). It is also known as 6-O-Methyl-15-norerythromycin A. Clarithromycin EP Impurity B is supplied with detailed characterization data compliant with regulatory guideline. Clarithromycin EP Impurity B can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Clarithromycin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility

Clarithromycin EP Impurity A  is chemically 2-Demethyl-2-(hydroxymethyl)-6-O-methylerythromycin A (as per EP). It is also known as Clarithromycin F (EP) ; 2-Demethyl-2-(hydroxymethyl)-6-O-methylerythromycin A. Clarithromycin EP Impurity A  is supplied with detailed characterization data compliant with regulatory guideline. Clarithromycin EP Impurity A  can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Clarithromycin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility.

Clarithromycin EP Impurity H is chemically 3″-N-Demethyl-3′-N-formyl-6-O-methylerythromycin A (as per EP). It is also known as N-Demethyl-N-formyl Clarithromycin. Clarithromycin EP Impurity H is supplied with detailed characterization data compliant with regulatory guideline. Clarithromycin EP Impurity H can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Clarithromycin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility

Clarithromycin EP Impurity P is chemically 4′,6-Di-O-methylerythromycin A (as per EP). Clarithromycin EP Impurity P is supplied with detailed characterization data compliant with regulatory guideline. Clarithromycin EP Impurity P can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Clarithromycin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility